Alitretinoin Other names: 9-cis-retinoic acid Alitretinoin

Chemical formula: C₂₀H₂₈O₂  Molecular mass: 300.435 g/mol  PubChem compound: 449171

Therapeutic indications

Alitretinoin is indicated for:

AIDS related Kaposi’s sarcoma

Population group: men, only adults (18 - 65 years old)

Alitretinoin is indicated for the topical treatment of cutaneous lesions in patients with AIDS related Kaposi’s sarcoma (KS) when:

  • lesions are not ulcerated or lymphoedematous
  • treatment of visceral KS is not required
  • lesions are not responding to systemic antiretroviral therapy
  • radiotherapy or chemotherapy are not appropriate

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Severe chronic hand eczema

Population group: only adults (18 - 65 years old)

Alitretinoin is indicated for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids.

Patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Alitretinoin is contraindicated in the following cases:

Pregnancy

Pregnancy

Breast-feeding

Lactation

Hepatic insufficiency

Hepatic insufficiency

Severe renal insufficiency

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Hypercholesterolemia, hypertriglyceridemia

at least one of
Hypercholesterolemia
Hypertriglyceridaemia

Hypothyroidism

Hypothyroidism

Hypervitaminosis A

Hypervitaminosis A

Tetracyclines

Tetracyclines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: PANRETIN Gel
Summary of Product Characteristics (SPC) 2020: TOCTINO Capsule, soft
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈